- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jenburkt Pharmaceuticals Ltd (JENA)Jenburkt Pharmaceuticals Ltd stock price live, this page displays BO JENA stock exchange data. View the JENA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jenburkt Pharmaceuticals Ltd real time stock price chart below.
What Is the Jenburkt Pharmaceuticals Ltd Stock Price Today?
The Jenburkt Pharmaceuticals Ltd stock price today is 1,276.00.
What Is the Stock Symbol for Jenburkt Pharmaceuticals Ltd?
The stock symbol for Jenburkt Pharmaceuticals Ltd is "JENA."
What Stock Exchange Does Jenburkt Pharmaceuticals Ltd Trade On?
Jenburkt Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Jenburkt Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Jenburkt Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JENA quote. (ISIN: INE354A01013)
What Is the Jenburkt Pharmaceuticals Ltd Stock Price Today?
The Jenburkt Pharmaceuticals Ltd stock price today is 1,276.00.
What Is the Stock Symbol for Jenburkt Pharmaceuticals Ltd?
The stock symbol for Jenburkt Pharmaceuticals Ltd is "JENA."
What Stock Exchange Does Jenburkt Pharmaceuticals Ltd Trade On?
Jenburkt Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Jenburkt Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Jenburkt Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JENA quote. (ISIN: INE354A01013)
BSE
Currency in INR
1,276.00
-49.60(-3.74%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,250.00
1,305.00
52 wk Range
643.20
1,375.00
JENA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,250.001,305.00
52 wk Range
643.201,375.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JENA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
Jenburkt Pharma Company Profile
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical and healthcare products in India. It offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, antifungals, antiulcerants/antacids, aphrodisiacs, antimalarials, anthelmintics, cough and cold, and anti- diabetics, as well as consumer products. The company offers its products under the Allerzine, CartiSafe Forte, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, Zydol Suspension, and Zixa brand names. The company provides its products through stockists, doctors, pharmacies, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It exports its products to approximately 13 countries worldwide. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
Compare JENA to Peers and Sector
Metrics to compare | JENA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJENAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.5x | 38.9x | −0.6x | |
PEG Ratio | 0.88 | 0.49 | 0.00 | |
Price/Book | 3.6x | 5.7x | 2.6x | |
Price / LTM Sales | 3.8x | 5.7x | 3.2x | |
Upside (Analyst Target) | - | 13.0% | 45.4% | |
Fair Value Upside | Unlock | −15.6% | 7.7% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 68.66
Dividend Yield
1.19%
Industry Median 0.71%
Annualised payout
15.3000
Paid annually
5-Years Growth
-
Growth Streak
FAQ
What Is the Jenburkt Pharma (JENA) Stock Price Today?
The Jenburkt Pharma stock price today is 1,276.00.
What Stock Exchange Does Jenburkt Pharma Trade On?
Jenburkt Pharma is listed and trades on the BSE stock exchange.
What Is the Stock Symbol for Jenburkt Pharma?
The stock symbol for Jenburkt Pharma is "JENA."
Does Jenburkt Pharma Pay Dividends? What’s The Current Dividend Yield?
The Jenburkt Pharma dividend yield is 1.15%.
What Is the Jenburkt Pharma Market Cap?
As of today, Jenburkt Pharma market cap is 5.63B.
What is Jenburkt Pharma Earnings Per Share?
The Jenburkt Pharma EPS is 68.66.
What Is the Next Jenburkt Pharma Earnings Date?
Jenburkt Pharma will release its next earnings report on 10 Feb 2025.
From a Technical Analysis Perspective, Is JENA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.